Loading
Latest filing published 26 Apr 2006 for SEROLOGICALS CORP, €1,207.
No signal scores available.
Aaron J. Shatkin discloses dealings in Serologicals Corp to SEC (Form 4). We count 3 filings; the first trade dates from 10 February 2006 and the latest from 24 April 2006.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 26 April 2006: a share grant of €1,207, in Serologicals Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations